Your shopping cart is currently empty

PG-901 is a full and selective MC5R agonist, exhibiting an EC50 of 0.072 nM for hMC5R. It also acts as a complete antagonist for hMC3R and hMC4R, with Kb values of 1.0 nM and 0.53 nM, respectively. Additionally, PG-901 significantly reduces the levels of cytokines (IL-1α, IL-1β, and IL-6), enhances glucose tolerance, lowers blood sugar, and mitigates retinal damage.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | PG-901 is a full and selective MC5R agonist, exhibiting an EC50 of 0.072 nM for hMC5R. It also acts as a complete antagonist for hMC3R and hMC4R, with Kb values of 1.0 nM and 0.53 nM, respectively. Additionally, PG-901 significantly reduces the levels of cytokines (IL-1α, IL-1β, and IL-6), enhances glucose tolerance, lowers blood sugar, and mitigates retinal damage. |
| Targets&IC50 | MC5R:0.072 nM (EC50) |
| Molecular Weight | 1034.23 |
| Formula | C53H71N13O9 |
| Cas No. | 322639-20-3 |
| Smiles | C(C=1C=2C(NC1)=CC=CC2)[C@@H]3NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CC4=CC5=C(C=C4)C=CC=C5)NC(=O)[C@]6(N(C(=O)[C@@H](NC([C@H](CCCC)NC(C)=O)=O)CC(=O)NCCCC[C@@H](C(N)=O)NC3=O)CCC6)[H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.